U.S. FDA Clears Avita Medical’s Cohealyx for Healing Full-thickness Wounds
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Cohealyx, a new collagen-based dermal matrix designed for tissue integration and revascularization to facilitate wound healing. Branded by AVITA Medical and co-developed with Regenity Biosciences, Cohealyx may reduce treatment timelines, and improve patient outcomes in the treatment of full-thickness wounds. Cohealyx comprises a […]